$EBS - Narcan over the counter nose spray & Earnings 2/27

Emergent Biosolutions, Inc. (NYSE:EBS)

NYSE:EBS Emergent Biosolutions, Inc.

Technical Indicators Fundamental Analysis

I usually stray away from bio/biotech b/c of how volatile it is, but $EBS seems to be established with a $800M+ market cap, strong historicals, 20 PE ratio, and seems to be getting close to bottom. They also have an exciting narcan nasal spray product that can be sold over the counter they are working on releasing in 2023. Very relevant with all the overdoses going on in the US.

What do you guys think?

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.